Cencora, Inc. (COR) compared with its closest peers (MCK, CAH, CI, SYY, MDLN): P/E 24.5 vs industry 23.9. Peer set by Wholesale; 10 comparable wholesalers. First-party data.
McKesson and Cardinal Health share Cencora's sub-industry, drug wholesalers; Cigna, Sysco, Medline, Henry Schein and Amneal Pharmaceuticals share Cencora's business model, drug distributor / pharmaceutical wholesale.
| Company | Market Cap | P/E |
|---|---|---|
| McKesson Corporation (MCK) | $107.40B | 23.4 |
| Cardinal Health, Inc. (CAH) | $57.81B | 34.8 |
| Cigna Corporation (CI) | $75.64B | 12.1 |
| Sysco Corporation (SYY) | $38.77B | 22.1 |
| Medline Inc. (MDLN) | $31.52B | 30.7 |
| Henry Schein, Inc. (HSIC) | $10.13B | 25.1 |
| TD SYNNEX Corporation (SNX) | $21.09B | 18.6 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $5.70B | 36.2 |
| Ryerson Holding Corp (RYZ) | $1.34B | — |
| ScanSource, Inc. (SCSC) | $1.17B | 14.8 |
| Stock P/E | 24.5 |
| Sector P/E (Consumer Discretionary) | 20.2 |
| Industry P/E (Wholesale) | 23.9 |
| vs Sector | 21.6% |
| vs Industry | 2.8% |
COR overview · COR earnings · COR financials · COR KPIs · COR documents · COR ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.